Physician profile
George J Haidukewych
NPI 1023013737
$10,012,968.54
in general payments reported to CMS, 2019-2025
17 companies · $2.2M in 2025
The $2.2M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.0M · 2020: $813K · 2021: $875K · 2022: $1.4M · 2023: $1.8M · 2024: $1.9M · 2025: $2.2M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $5.3M · Consulting Fee: $409K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $163K · Travel and Lodging: $67K · Food and Beverage: $14K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,257,297.01 |
| Consulting Fee | $409,023.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $163,126.00 |
| Travel and Lodging | $67,303.96 |
| Food and Beverage | $13,568.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $7,876,557.12 | 2019-2025 | Na, Attune |
| Zimmer Biomet Holdings, INC. | $1,192,225.56 | 2019-2025 | Affixus, A.L.P.S. |
| Smith+Nephew, INC. | $691,251.44 | 2021-2025 | Real Intelligence, Or3o Dual Mobility, Journey II |
| Medical Device Business Services, INC. | $74,164.63 | 2019-2025 | Na, Sigma, Tfn-Advance |
| Conformis, INC. | $71,274.67 | 2019-2023 | Actera Hip Stem |
| Pacira Pharmaceuticals Incorporated | $52,712.73 | 2019-2021 | |
| Medtronic USA, INC. | $43,000.00 | 2019 | |
| Synthes USA Products LLC | $7,616.66 | 2019-2021 | |
| Stryker Corporation | $2,525.28 | 2019-2025 | Mako |
| Globus Medical, INC. | $552.91 | 2020-2021 | |
| Arthrex, INC. | $400.65 | 2021 | |
| Corin USA | $195.26 | 2019 | |
| Depuy Synthes Sales INC. | $164.78 | 2021 | |
| Innovation Technologies INC | $133.64 | 2023 | Irrisept |
| Biocomposites INC | $99.34 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omnilife Science, INC | $72.99 | 2025 | |
| Endo Pharmaceuticals INC. | $20.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Haidukewych listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.